Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

1. Welte, T.
2. Dellinger, R.P.
3. Ebelt, H.
4. Ferrer, M.
5. Opal, S.M.
6. Singer, M.
7. Vincent, J.-L.
8. Werdan, K.
9. Martin-Loeches, I.
10. Almirall, J.
11. Artigas, A.
12. Ignacio Ayestarán, J.
13. Nuding, S.
14. Ferrer, R.
15. Sirgo Rodríguez, G.
16. Shankar-Hari, M.
17. Álvarez-Lerma, F.
18. Riessen, R.
19. Sirvent, J.-M.
20. Kluge, S.
21. Zacharowski, K.
22. Bonastre Mora, J.
23. Lapp, H.
24. Wöbker, G.
25. Achtzehn, U.
26. Brealey, D.
27. Kempa, A.
28. Sánchez García, M.
29. Brederlau, J.
30. Kochanek, M.
31. Reschreiter, H.P.
32. Wise, M.P.
33. Belohradsky, B.H.
34. Bobenhausen, I.
35. Dälken, B.
36. Dubovy, P.
37. Langohr, P.
38. Mayer, M.
39. Schüttrumpf, J.
40. Wartenberg-Demand, A.
41. Wippermann, U.
42. Wolf, D.
43. Torres, A.
44. Show all authors +